D
Beyond Medical Technologies Inc. DOCT
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -46.35% -4.74% -24.87% 0.69% -17.48%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -46.35% -4.74% -24.87% 0.69% -17.48%
Operating Income 46.35% 4.74% 24.87% -0.69% 17.48%
Income Before Tax 45.63% 3.66% 66.08% 50.26% 19.64%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 45.63% 3.66% 66.08% 50.26% 19.64%
Earnings from Discontinued Operations 100.00% -94.12% 23.83% 102.94% 58.98%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 67.91% 1.74% 120.05% 52.06% 42.31%
EBIT 46.35% 4.74% 24.87% -0.69% 17.48%
EBITDA -- -- -- -- --
EPS Basic 67.93% 1.06% 120.20% 52.38% 42.48%
Normalized Basic EPS 44.32% 3.33% 24.24% 5.26% 19.27%
EPS Diluted 67.93% 1.06% 120.20% 52.38% 42.48%
Normalized Diluted EPS 44.32% 3.33% 24.24% 5.26% 19.27%
Average Basic Shares Outstanding 0.00% 0.00% 0.00% 0.00% 0.00%
Average Diluted Shares Outstanding 0.00% 0.00% 0.00% 0.00% 0.00%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --